Literature DB >> 1260223

Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.

M O Carruba, A Groppetti, P Mantegazza, L Vicentini, F Zambotti.   

Abstract

1 Mazindol is a new anorexigenic agent which possesses a different chemical structure from that of phenylethylamines, but shows a pharmacological profile similar to that of (+)-amphetamine. 2 Mazindol neither altered whole brain monoamine levels (noradrenaline (NA), dopamine, 5-hydroxytryptamine (5-HT)) nor changed NA levels in the hypothalamus or dopamine levels in the caudate nucleus. 3 Mazindol enhanced dopamine turnover rate in the caudate nucleus, as shown by the increased rate of dopamine decline after blockade of catecholamine synthesis by alpha-methyl-p-tyrosine and decreased the conversion index of (3H)-tyrosine into brain NA. 4 Mazindol administration did not modify pargyline-induced decline of 5-hydroxyindoleacetic acid suggesting that 5-HT turnover is not altered by this drug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260223      PMCID: PMC1666899          DOI: 10.1111/j.1476-5381.1976.tb07454.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  [Anorexigenic phenylalkylamines and serotonin metabolism].

Authors:  K Opitz
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

2.  Is 5-hydroxytryptamine involved in the mechanism of action of fenfluramine?

Authors:  W H Funderburk; J C Hazelwood; R T Ruckart; J W Ward
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

3.  On the effect of anorectic drugs on striatum homovanillic acid in rats.

Authors:  A Jori; E Dolfini
Journal:  Pharmacol Res Commun       Date:  1974-04

4.  The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine.

Authors:  R Samanin; D Ghezzi; L Valzelli; S Garattini
Journal:  Eur J Pharmacol       Date:  1972-09       Impact factor: 4.432

5.  A simple procedure for calculating the synthesis rate of norepinephrine, dopamine and serotonin in rat brain.

Authors:  N H Neff; P F Spano; A Groppetti; C T Wang; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1971-03       Impact factor: 4.030

6.  The role of brain serotonin in the mechanism of the central action of reserpine.

Authors:  B B Brodie; M S Comer; E Costa; A Dlabac
Journal:  J Pharmacol Exp Ther       Date:  1966-05       Impact factor: 4.030

7.  [Modification of the cerebral serotonin level in the rat by trifluoromethyl-2-phenyl ethyl aminopropane (Fenfluramine 768 S)].

Authors:  J Duhault; C Verdavainne
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-12

8.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

9.  The effects of 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo (2, 1-a) isoindole (mazindol, SaH 42-548) on the metabolism of brain norepinephrine.

Authors:  R G Engstrom; L A Kelly; J H Gogerty
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-04

10.  Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia.

Authors:  S Jespersen; J Scheel-Krüger
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

View more
  6 in total

1.  Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.

Authors:  M O Carruba; G B Picotti; F Zambotti; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  The anorectic action of mazindol.

Authors:  K F Sweeney
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

3.  Inhibition of foot intake in the rat.

Authors:  N Blavet; F V DeFeudis
Journal:  Neurochem Res       Date:  1982-03       Impact factor: 3.996

4.  Mazindol anorexia is mediated by activation of dopaminergic mechanisms.

Authors:  Z L Kruk; M R Zarrindast
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

5.  Effect of mazindol on brain dopamine turnover in spiperone-treated rats.

Authors:  R W Fuller; H D Snoddy
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

6.  Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.

Authors:  M O Carruba; G B Picotti; F Zambotti; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.